VNDA Stock Analysis: Buy, Sell, or Hold?
VNDA - Vanda Pharmaceuticals Inc.
$7.16
-0.06 (-0.83%)
▼
5d:
+2.73%
30d:
-22.93%
90d:
-2.32%
BUY
HIGH Confidence
Analysis Updated: Apr 13, 2026 12:00 AM ET
Earnings: May 06, 2026
21d
Smart Money Accumulation
VNDA is down 4.3% this week, but smart money is accumulating calls. Top strike: $8 2026-06-18 with 1,886 OI. Call ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When VNDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: VNDA is currently trading at $7.16, which is considered slightly low relative to its 30-day fair value range of $7.02 to $8.79.
Technical Outlook: Technically, VNDA is in a uptrend. Immediate support is located at $6.57, while resistance sits at $7.79.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+116.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VNDA is in a uptrend. Immediate support is located at $6.57, while resistance sits at $7.79.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+116.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.02 -
$8.79
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 116.5% below Wall St target ($15.50)
Fair Price Analysis
30-Day Fair Range
$7.02 -
$8.79
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.57
Resistance Level
$7.79
Current Trend
Uptrend
Technical data as of
Apr 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.04
Wall Street Target
$15.50
(+116.5%)
Revenue Growth (YoY)
7.6%
Earnings Growth (YoY)
-95.9%
Profit Margin
-102.0%
Share & Embed Analysis
Last updated: April 13, 2026 7:46 PM ET
Data refreshes hourly during market hours. Next update: 8:46 PM
Data refreshes hourly during market hours. Next update: 8:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Gunther Birznieks
SELL
42431 shares
2026-03-02
Joakim Wijkstrom
SELL
30800 shares
2026-03-02
Kevin Patrick Moran
SELL
42442 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 60 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$212 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 52 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 57 HOLD |
